lose weight with glp 1 Before & After Semaglutide GLP-1 Loss Understanding GLP-1 and Its Role

Understanding their models, eligibility criteria, and clinical workflows can help patients and providers make informed decisions about medication fit

GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.

Beyond their impact on weight, these medications have shown promise in ameliorating obesity-related health markers, including lowering blood pressure, improving lipid profiles, and enhancing glycemic control (Marso et al., 2016)

PlexusDx helps you find your tolerance level without overpaying

Compounded tirzepatide is not reviewed or approved by the FDA for safety or effectiveness

GLP-X is your triple-action wellness ally